HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.

AbstractOBJECTIVE:
To investigate the potential benefit of periocular depot triamcinolone in the prevention of macular edema after iodine 125 plaque radiotherapy for uveal melanoma.
METHODS:
This comparative, nonrandomized, interventional study included 87 patients with uveal melanoma who underwent plaque radiotherapy. The triamcinolone group included 55 consecutive patients who were treated with 40 mg of periocular triamcinolone at the time of plaque application and 4 months and 8 months later. The comparison group comprised 32 consecutive patients treated with plaque radiotherapy without triamcinolone. Patients were evaluated at 4 months, 8 months, 12 months, 18 months, and 24 months after plaque application with clinical examination, fundus photography, and optical coherence tomography (OCT). The associations of clinical variables with the development of OCT-evident macular edema (the main outcome measure) were investigated using Cox proportional hazards analysis.
RESULTS:
By multivariate analysis, eyes treated with periocular triamcinolone had a significant reduction in the risk of radiation-induced macular edema (P = 0.002; hazard estimate = 0.49; 95% confidence interval, 0.17- 0.80). Adverse effects associated with periocular triamcinolone treatment included elevation of intraocular pressure (7% of cases) and blepharoptosis (5% of cases).
CONCLUSIONS:
Periocular triamcinolone treatment significantly lowered the risk of macular edema after plaque radiotherapy for uveal melanoma in this series but did not significantly alter the rate of vision loss at 24 months of follow-up.
AuthorsNoel Horgan, Carol L Shields, Arman Mashayekhi, Luiz F Teixeira, Miguel A Materin, Myra O'Regan, Jerry A Shields
JournalRetina (Philadelphia, Pa.) (Retina) 2008 Jul-Aug Vol. 28 Issue 7 Pg. 987-95 ISSN: 0275-004X [Print] United States
PMID18698302 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Iodine Radioisotopes
  • Triamcinolone Acetonide
Topics
  • Brachytherapy (adverse effects)
  • Female
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Injections
  • Iodine Radioisotopes (adverse effects)
  • Macula Lutea (radiation effects)
  • Macular Edema (etiology, prevention & control)
  • Male
  • Melanoma (radiotherapy)
  • Middle Aged
  • Proportional Hazards Models
  • Radiation Injuries (etiology, prevention & control)
  • Triamcinolone Acetonide (adverse effects, therapeutic use)
  • Uveal Neoplasms (radiotherapy)
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: